AIMT insider filings

Aimmune Therapeutics, Inc. — 22 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-10-15. Screen AIMT transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AIMT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Aimmune Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2020-10-154Societe des Produits Nestle S.A. — 10% ownerPurchase (P): 43,435,583 @ $34.50 · Purchase (P): 10,681,704 @ $34.50EDGAR
2020-10-144Oxtoby Andrew — Chief Commercial OfficerCode (U): 6,345 @ $34.50 · Disposition to issuer (D): 20,250 @ $34.50 · Disposition to issuer (D): 150,000 (derivative) @ $12.56 · Disposition to issuer (D): 67,500 (derivative) @ $10.69EDGAR
2020-10-144Dallas Jayson Donald Alexander — President and CEO, DirectorCode (U): 30,422 @ $34.50 · Disposition to issuer (D): 89,250 @ $34.50 · Disposition to issuer (D): 350,000 (derivative) @ $3.82 · Disposition to issuer (D): 210,000 (derivative) @ $10.78 · Disposition to issuer (D): 200,000 (derivative) @ $10.69EDGAR
2020-10-144Behar Gregory — DirectorOther (J): 10,192 @ $0 · Disposition to issuer (D): 7,840 @ $34.50 · Disposition to issuer (D): 39,510 (derivative) @ $9.60 · Disposition to issuer (D): 17,500 (derivative) @ $16.24 · Disposition to issuer (D): 7,500 (derivative) @ $1.71 · Disposition to issuer (D): 11,432 (derivative) @ $14.60 · +1 moreEDGAR
2020-10-144Seltzer Stacey Denenberg — DirectorCode (U): 10,221 @ $34.50 · Disposition to issuer (D): 7,840 @ $34.50 · Disposition to issuer (D): 52,421 (derivative) @ $28.21 · Disposition to issuer (D): 19,755 (derivative) @ $19.10 · Disposition to issuer (D): 17,500 (derivative) @ $16.24 · Disposition to issuer (D): 7,500 (derivative) @ $1.71 · +2 moreEDGAR
2020-10-144HAUMANN BRETT K — DirectorCode (U): 6,250 @ $34.50 · Disposition to issuer (D): 13,313 @ $34.50 · Disposition to issuer (D): 25,453 (derivative) @ $17.39EDGAR
2020-10-144Sheehy Douglas T. — See RemarksCode (U): 47,450 @ $34.50 · Disposition to issuer (D): 36,875 @ $34.50 · Disposition to issuer (D): 22,361 (derivative) @ $21.55 · Disposition to issuer (D): 67,500 (derivative) @ $14.87 · Disposition to issuer (D): 75,000 (derivative) @ $0.43 · Disposition to issuer (D): 75,000 (derivative) @ $10.78 · +1 moreEDGAR
2020-10-144Iwicki Mark T — DirectorCode (U): 39,567 @ $34.50 · Disposition to issuer (D): 7,840 @ $34.50 · Disposition to issuer (D): 52,421 (derivative) @ $31.48 · Disposition to issuer (D): 87,368 (derivative) @ $28.21 · Disposition to issuer (D): 19,755 (derivative) @ $19.10 · Disposition to issuer (D): 17,500 (derivative) @ $16.24 · +3 moreEDGAR
2020-10-144ENRIGHT PATRICK G — DirectorCode (U): 70,561 @ $34.50 · Code (U): 91,697 @ $34.50 · Disposition to issuer (D): 7,840 @ $34.50 · Disposition to issuer (D): 65,849 (derivative) @ $34.36 · Disposition to issuer (D): 52,421 (derivative) @ $28.21 · Disposition to issuer (D): 19,755 (derivative) @ $19.10 · +4 moreEDGAR
2020-10-144MCDADE MARK — DirectorCode (U): 26,852 @ $34.50 · Disposition to issuer (D): 7,840 @ $34.50 · Disposition to issuer (D): 104,842 (derivative) @ $31.48 · Disposition to issuer (D): 19,755 (derivative) @ $19.10 · Disposition to issuer (D): 17,500 (derivative) @ $16.24 · Disposition to issuer (D): 7,500 (derivative) @ $1.71 · +2 moreEDGAR
2020-10-144ADELMAN DANIEL C MD — Chief Medical OfficerCode (U): 41,464 @ $34.50 · Disposition to issuer (D): 22,343 @ $34.50 · Disposition to issuer (D): 135,068 (derivative) @ $23.05 · Disposition to issuer (D): 70,000 (derivative) @ $14.87 · Disposition to issuer (D): 56,250 (derivative) @ $0.43 · Disposition to issuer (D): 71,250 (derivative) @ $10.78 · +1 moreEDGAR
2020-10-144FALBERG KATHRYN E — DirectorCode (U): 65,192 @ $34.50 · Code (U): 69,894 @ $34.50 · Disposition to issuer (D): 7,840 @ $34.50 · Disposition to issuer (D): 19,755 (derivative) @ $19.10 · Disposition to issuer (D): 17,500 (derivative) @ $16.24 · Disposition to issuer (D): 7,500 (derivative) @ $1.71 · +2 moreEDGAR
2020-10-144BJERKHOLT ERIC — Chief Financial OfficerCode (U): 27,805 @ $34.50 · Disposition to issuer (D): 23,905 @ $34.50 · Disposition to issuer (D): 264,800 (derivative) @ $15.06 · Disposition to issuer (D): 56,250 (derivative) @ $0.43 · Disposition to issuer (D): 78,750 (derivative) @ $10.78 · Disposition to issuer (D): 56,250 (derivative) @ $10.69EDGAR
2020-10-054Sheehy Douglas T. — See RemarksOption exercise (M): 30,888 @ $12.95 · Option exercise (M): 30,888 (derivative) @ $0EDGAR
2020-10-054ADELMAN DANIEL C MD — Chief Medical OfficerOption exercise (M): 34,932 @ $11.45 · Option exercise (M): 34,932 (derivative) @ $0EDGAR
2020-10-054BJERKHOLT ERIC — Chief Financial OfficerOption exercise (M): 5,200 @ $19.44 · Option exercise (M): 5,200 (derivative) @ $0EDGAR
2020-09-234ENRIGHT PATRICK G — DirectorOther (J): 6,113,134 @ $0 · Other (J): 91,697 @ $0EDGAR
2020-09-164Oxtoby Andrew — Chief Commercial OfficerTax withholding (F): 840 @ $34.25EDGAR
2020-09-164Dallas Jayson Donald Alexander — President and CEO, DirectorTax withholding (F): 1,642 @ $34.25EDGAR
2020-09-164Sheehy Douglas T. — See RemarksTax withholding (F): 840 @ $34.25EDGAR
2020-09-164ADELMAN DANIEL C MD — Chief Medical OfficerTax withholding (F): 840 @ $34.25EDGAR
2020-09-164BJERKHOLT ERIC — Chief Financial OfficerTax withholding (F): 840 @ $34.25EDGAR

Recent 8-K events — Aimmune Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2020-10-198-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2020-08-318-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AIMT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs